Companies › LIVN
LIVANOVA PLC SHS (LIVN)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001639691 · EDGAR filings · Updated 2026-06-17
LIVANOVA PLC SHS (LIVN) has reported institutional ownership of 31.1%, with 291 institutional managers holding positions valued at $3.73B per the latest 13F reporting period. SEC filings include an active material impairment disclosure (8-K Item 2.06), substantial-doubt (going concern) disclosure per the filings.
Latest updates
- 2026-06-17 — Insider transaction reported (Form 4)
- 2026-06-17 — Insider transaction reported (Form 4)
- 2026-06-17 — Insider transaction reported (Form 4)
- 2026-06-17 — Insider transaction reported (Form 4)
- 2026-06-17 — Insider transaction reported (Form 4)
- 2026-06-17 — Insider transaction reported (Form 4)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, LIVANOVA PLC SHS has 291 institutional holders and institutional ownership of 31.1%.
Insider activity
Insiders reported 43 transactions (0 buys, 2 sells) across 16 reporting insiders, with a net reported value of −$98.2K.
Data flags from SEC filings
Related companies
SOTERA HEALTH CO (SHC) · INDIVIOR PHARMACEUTICALS INC (INDV) · TANGO THERAPEUTICS INC (TNGX) · EDGEWISE THERAPEUTICS INC (EWTX) · CRISPR THERAPEUTICS AG (CRSP) · ACADIA PHARMACEUTICALS INC COM (ACAD)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-17.